2-O-α-D-Glucopyranosyl-L-ascorbic acid (AA-2G) is an industrially important derivative of vitamin C [Lascorbic acid (L-AA)]. A useful synthetic route toward AA-2G is the selective glucosylation of L-AA by cyclodextrin glucanotransferase (CGTase). However, the cyclodextrin donor substrate is utilized rather inefficiently, because only one of its constituent glucosyl residues is coupled to the L-AA acceptor. A CGTase catalyzing disproportionation of the linear maltooligosaccharide chain formed in the initial coupling reaction might utilize a greater portion of the substrate for L-AA glucosylation and thus boost the AA-2G yield of cyclodextrin conversion. We present here a detailed characterization of the transfer reactions involved in the formation of AA-2G from α-cyclodextrin by a commercial CGTase preparation from Thermoanaerobacter sp. (Toruzyme 3.0L). We demonstrate that besides coupling, disproportionation constitutes a major route of glucosylation of L-AA by this enzyme. L-AA glucosides with oligoglucosyl chains between 1 and 12 units long were produced in the reaction. After chain-trimming hydrolysis with glucoamylase, however, AA-2G was recovered as the sole product of the enzymatic transglucosylation. The molar yield of AA-2G from cyclodextrin was 1.4, thus clearly exceeding the maximal yield of 1 for the coupling reaction. Using conditions optimized for transfer efficiency and productivity, we obtained AA-2G at the highest concentration (143 g/L, 424 mM) so far reported from an enzymatic glucosylation of L-AA. The synthetic yield was 30% based on L-AA (250 g/L, 1420 mM) offered in ≤4.6-fold molar excess over α-cyclodextrin.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.